These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32882218)

  • 1. CSN6 aggravates Ang II-induced cardiomyocyte hypertrophy via inhibiting SIRT2.
    Mei ZL; Wang HB; Hu YH; Xiong L
    Exp Cell Res; 2020 Nov; 396(1):112245. PubMed ID: 32882218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PHD Finger Protein 19 Promotes Cardiac Hypertrophy via Epigenetically Regulating SIRT2.
    Gu W; Cheng Y; Wang S; Sun T; Li Z
    Cardiovasc Toxicol; 2021 Jun; 21(6):451-461. PubMed ID: 33611744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein.
    Ma F; Wang H; Liu K; Wang Z; Chen S
    Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced cardiac hypertrophy.
    Lu P; Xu Y; Sheng ZY; Peng XG; Zhang JJ; Wu QH; Wu YQ; Cheng XS; Zhu K
    Exp Cell Res; 2021 Sep; 406(1):112761. PubMed ID: 34339675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSN5 attenuates Ang II-induced cardiac hypertrophy through stabilizing LKB1.
    Sheng Z; Xu Y; Li F; Wang S; Huang T; Lu P
    Exp Cell Res; 2019 Mar; 376(1):11-17. PubMed ID: 30710502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
    Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
    Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel circ_0018553 protects against angiotensin-induced cardiac hypertrophy in cardiomyocytes by modulating the miR-4731/SIRT2 signaling pathway.
    Zuo H; Li L; Wang X; Chen S; Liao Z; Wei S; Ruan H; Li T; Chen J
    Hypertens Res; 2023 Feb; 46(2):421-436. PubMed ID: 36474029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Emerging Role of CSN6 in Biological Behavior and Cancer Progress.
    Mao Z; Chen C; Pei DS
    Anticancer Agents Med Chem; 2019; 19(10):1198-1204. PubMed ID: 30961513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR.
    Hou J; Deng Q; Zhou J; Zou J; Zhang Y; Tan P; Zhang W; Cui H
    Oncogene; 2017 Feb; 36(8):1134-1144. PubMed ID: 27546621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
    Yu L; Meng W; Ding J; Cheng M
    Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CIKS (Act1 or TRAF3IP2) mediates Angiotensin-II-induced Interleukin-18 expression, and Nox2-dependent cardiomyocyte hypertrophy.
    Valente AJ; Clark RA; Siddesha JM; Siebenlist U; Chandrasekar B
    J Mol Cell Cardiol; 2012 Jul; 53(1):113-24. PubMed ID: 22575763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSN6, a subunit of the COP9 signalosome, is involved in early response to iron deficiency in Oryza sativa.
    Tan S; Liu F; Pan XX; Zang YP; Jin F; Zu WX; Qi XT; Xiao W; Yin LP
    Sci Rep; 2016 May; 6():25485. PubMed ID: 27137867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP.
    Li N; Wang HX; Han QY; Li WJ; Zhang YL; Du J; Xia YL; Li HH
    J Mol Cell Cardiol; 2015 Feb; 79():303-14. PubMed ID: 25526681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.
    Gomes ER; Lara AA; Almeida PW; Guimarães D; Resende RR; Campagnole-Santos MJ; Bader M; Santos RA; Guatimosim S
    Hypertension; 2010 Jan; 55(1):153-60. PubMed ID: 19996065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EndophilinA2 protects against angiotensin II-induced cardiac hypertrophy by inhibiting angiotensin II type 1 receptor trafficking in neonatal rat cardiomyocytes.
    Liu Y; Shen HJ; Wang XQ; Liu HQ; Zheng LY; Luo JD
    J Cell Biochem; 2018 Nov; 119(10):8290-8303. PubMed ID: 29923351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-92b-3p suppresses angiotensin II-induced cardiomyocyte hypertrophy via targeting HAND2.
    Yu XJ; Huang YQ; Shan ZX; Zhu JN; Hu ZQ; Huang L; Feng YQ; Geng QS
    Life Sci; 2019 Sep; 232():116635. PubMed ID: 31283925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-122 promotes cardiomyocyte hypertrophy via targeting FoxO3.
    Song G; Zhu L; Ruan Z; Wang R; Shen Y
    Biochem Biophys Res Commun; 2019 Nov; 519(4):682-688. PubMed ID: 31543343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSN6 Promotes the Migration and Invasion of Cervical Cancer Cells by Inhibiting Autophagic Degradation of Cathepsin L.
    Mao Z; Sang MM; Chen C; Zhu WT; Gong YS; Pei DS
    Int J Biol Sci; 2019; 15(6):1310-1324. PubMed ID: 31223289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.